{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:20:39Z","timestamp":1783455639821,"version":"3.55.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020230","name":"Jilin Province Health Commission","doi-asserted-by":"publisher","award":["2024A121"],"award-info":[{"award-number":["2024A121"]}],"id":[{"id":"10.13039\/501100020230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS168"],"award-info":[{"award-number":["YDZJ202201ZYTS168"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103343"],"award-info":[{"award-number":["82103343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.critrevonc.2026.105295","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:50:39Z","timestamp":1774396239000},"page":"105295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The oncogene c-MYC: An orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer"],"prefix":"10.1016","volume":"222","author":[{"given":"Peiyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105295_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrm1703","article-title":"Transcriptional regulation and transformation by Myc proteins","volume":"6","author":"Adhikary","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib2","article-title":"MYC activation impairs cell-intrinsic IFN\u03b3 signaling and confers resistance to anti-PD1\/PD-L1 therapy in lung cancer","volume":"4","author":"Alburquerque-Bejar","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib3","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/MCB.26.7.2832-2844.2006","article-title":"Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation","volume":"26","author":"Arnold","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-020-0215-2","article-title":"Target gene-independent functions of MYC oncoproteins","volume":"21","author":"Baluapuri","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5012","article-title":"Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy","volume":"11","author":"Beaulieu","year":"2019","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.565820","article-title":"The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer","volume":"10","author":"Bian","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.celrep.2016.06.081","article-title":"ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs","volume":"16","author":"Borromeo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/15384101.2017.1339849","article-title":"Family matters: how MYC family oncogenes impact small cell lung cancer","volume":"16","author":"Br\u00e4gelmann","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2026.105295_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acr.2021.07.004","article-title":"Not all RAS mutations are equal: a detailed review of the functional diversity of RAS hot spot mutations","volume":"153","author":"Burge","year":"2022","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cllc.2021.04.005","article-title":"A phase II trial of prexasertib (LY2606368) in patients with extensive-stage small-cell lung cancer","volume":"22","author":"Byers","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib12","article-title":"ARID1A governs genomic stability and proliferation in SCLC via c-MYC\/PARP1 suppression driving vulnerability to BET inhibitors","volume":"8","author":"Cao","year":"2025","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.critrevonc.2026.105295_bib13","doi-asserted-by":"crossref","first-page":"73419","DOI":"10.18632\/oncotarget.20621","article-title":"Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies","volume":"8","author":"Cardnell","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105295_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.757323","article-title":"Alternative energy: breaking down the diverse metabolic features of lung cancers","volume":"11","author":"Cargill","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib16","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.21037\/tcr.2018.03.09","article-title":"Myc and ras, the bonnie and clyde of immune evasion","volume":"7","author":"Casacuberta-Serra","year":"2018","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.it.2017.01.002","article-title":"MYC: master regulator of immune privilege","volume":"38","author":"Casey","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib18","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2017-11-742577","article-title":"The MYC oncogene is a global regulator of the immune response","volume":"131","author":"Casey","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105295_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105295_bib20","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-18-4140","article-title":"MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion","volume":"25","author":"Chalishazar","year":"2019","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"key":"10.1016\/j.critrevonc.2026.105295_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/1535-7163.MCT-23-0602","article-title":"Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus","volume":"23","author":"Chang","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105295_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-023-02678-1","article-title":"MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat","volume":"42","author":"Chen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib23","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/2159-8290.CD-21-0441","article-title":"Rlf-mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer","volume":"11","author":"Ciampricotti","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrm2467","article-title":"Transcription-independent functions of MYC: regulation of translation and DNA replication","volume":"9","author":"Cole","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib25","doi-asserted-by":"crossref","first-page":"a014357","DOI":"10.1101\/cshperspect.a014357","article-title":"An overview of MYC and its interactome","volume":"4","author":"Conacci-Sorrell","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1101\/gad.231894.113","article-title":"Stress-induced cleavage of Myc promotes cancer cell survival","volume":"28","author":"Conacci-Sorrell","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105295_bib27","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41467-019-11371-x","article-title":"MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer","volume":"10","author":"Dammert","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105295_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molcel.2021.11.016","article-title":"MYC assembles and stimulates topoisomerases 1 and 2 in a \"topoisome\"","volume":"82","author":"Das","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature08697","article-title":"HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer","volume":"463","author":"David","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/JTO.0b013e318293d88c","article-title":"A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer","volume":"8","author":"de Marinis","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1183\/09031936.00105009","article-title":"Treatment of extensive-stage small cell lung carcinoma: current status and future prospects","volume":"35","author":"Demedts","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2026.105295_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"Dews","year":"2006","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2026.105295_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50731","article-title":"MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity","volume":"9","author":"Dhanasekaran","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.critrevonc.2026.105295_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12964-023-01260-8","article-title":"Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer","volume":"22","author":"Ding","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.critrevonc.2026.105295_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/2159-8290.CD-17-0935","article-title":"Genomic and functional fidelity of small cell lung cancer patient-derived xenografts","volume":"8","author":"Drapkin","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038240","article-title":"Advances in small-cell lung cancer (SCLC) translational research","volume":"11","author":"Drapkin","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.05.003","article-title":"Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer","volume":"42","author":"Finlay","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib39","doi-asserted-by":"crossref","first-page":"31014","DOI":"10.18632\/oncotarget.8826","article-title":"Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105295_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1541-7786.MCR-22-0165","article-title":"Dependence on the MUC1-C oncoprotein in classic, variant, and non-neuroendocrine small cell lung cancer","volume":"20","author":"Fushimi","year":"2022","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54917-1","article-title":"Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27","volume":"9","author":"Garc\u00eda-Guti\u00e9rrez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1415","article-title":"Lineage-specific intolerance to oncogenic drivers restricts histological transformation","volume":"383","author":"Gardner","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105295_bib43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/1078-0432.CCR-18-1129","article-title":"Differential sensitivity analysis for resistant malignancies (DISARM) identifies common candidate therapies across platinum-resistant cancers","volume":"25","author":"Gay","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib45","first-page":"2924","article-title":"Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties","volume":"45","author":"Gazdar","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib48","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","article-title":"Evolutionary trajectories of small cell lung cancer under therapy","volume":"627","author":"George","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","article-title":"Evolutionary trajectories of small cell lung cancer under therapy","volume":"627","author":"George","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-18-0469","article-title":"Aurora A kinase inhibition is synthetic lethal with loss of the RB1 tumor suppressor gene","volume":"9","author":"Gong","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib51","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.cels.2022.07.006","article-title":"Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer","volume":"13","author":"Groves","year":"2022","journal-title":"Cell Syst."},{"key":"10.1016\/j.critrevonc.2026.105295_bib52","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1101\/gad.340133.120","article-title":"MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity","volume":"34","author":"Grunblatt","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105295_bib53","first-page":"105","article-title":"Study on the biological function of abemecilib in inhibiting the proliferation, invasion and\u07edmigration of small cell lung cancer with high c-myc expression","volume":"26","author":"Guo","year":"2023","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.critrevonc.2026.105295_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s10020-025-01267-6","article-title":"ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer","volume":"31","author":"Guti\u00e9rrez","year":"2025","journal-title":"Mol. Med"},{"key":"10.1016\/j.critrevonc.2026.105295_bib55","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2174\/0115680096272757231211113206","article-title":"Bromodomain protein-directed agents and MYC in small cell lung cancer","volume":"24","author":"Hamilton","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.critrevonc.2026.105295_bib56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib57","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/1535-7163.MCT-16-0298","article-title":"Barasertib (AZD1152), a small molecule aurora b inhibitor, inhibits the growth of SCLC cell lines in vitro and in vivo","volume":"15","author":"Helfrich","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105295_bib58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1097-2765(02)00633-0","article-title":"Negative regulation of the mammalian UV response by Myc through association with Miz-1","volume":"10","author":"Herold","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139929","article-title":"Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer","volume":"131","author":"Huang","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2026.105295_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cmet.2018.06.005","article-title":"Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2026.105295_bib61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/his.12622","article-title":"Myc protein expression correlates with MYC amplification in small-cell lung carcinoma","volume":"67","author":"Hwang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2026.105295_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-025-09503-z","article-title":"Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer","volume":"647","author":"Ireland","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib65","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1172\/JCI112999","article-title":"myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course","volume":"79","author":"Johnson","year":"1987","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2026.105295_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0092-8674(83)90092-2","article-title":"Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor","volume":"35","author":"Kelly","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib67","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with ras by programming inflammation and immune suppression","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc3984","article-title":"MYC: connecting selective transcriptional control to global RNA production","volume":"15","author":"Kress","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib69","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-10-2259","article-title":"Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels","volume":"71","author":"Kretzner","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12957-024-03315-7","article-title":"C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer","volume":"22","author":"Lang","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib71","first-page":"3301","article-title":"Upregulation of Myc promotes the evasion of NK cell\u2011mediated immunity through suppression of NKG2D ligands in K562 cells","volume":"20","author":"Lee","year":"2019","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib72","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/1535-7163.MCT-15-0037","article-title":"Sensitivity of small cell lung cancer to BET inhibition is mediated by regulation of ASCL1 gene expression","volume":"14","author":"Lenhart","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105295_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13148-020-00839-z","article-title":"Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL\/MYC-signaling: effect on imatinib resistance and stem cells","volume":"12","author":"Lernoux","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.critrevonc.2026.105295_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/cas.16450","article-title":"Multiple kinase small molecule inhibitor tinengotinib (TT-00420) alone or with chemotherapy inhibit the growth of SCLC","volume":"116","author":"Li","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105295_bib75","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8333","article-title":"Colony\u2011stimulating factor CSF2 mediates the phenotypic plasticity of small\u2011cell lung cancer by regulating the p\u2011STAT3\/MYC pathway","volume":"48","author":"Li","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10565-025-10056-0","article-title":"Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survival","volume":"41","author":"Li","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib78","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/cas.15653","article-title":"Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation","volume":"114","author":"Liang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105295_bib79","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/306194a0","article-title":"Amplification and expression of the c-myc oncogene in human lung cancer cell lines","volume":"306","author":"Little","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","article-title":"Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib81","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41598-024-52687-z","article-title":"Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105295_bib82","article-title":"Differential expression of the MYC-Notch axis drives divergent responses to the front-line therapy in central and peripheral extensive-stage small-cell lung cancer","volume":"2020","author":"Luo","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.critrevonc.2026.105295_bib83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gene.2011.12.027","article-title":"Regulation of gene transcription by the oncoprotein MYC","volume":"494","author":"L\u00fcscher","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105295_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/0008-5472.CAN-17-1636","article-title":"MUC1-C induces PD-L1 and immune evasion in triple-negative breast cancer","volume":"78","author":"Maeda","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib85","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2014.02.031","article-title":"Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing","volume":"156","author":"McFadden","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207710","article-title":"MYC as a multifaceted regulator of tumor microenvironment leading to metastasis","volume":"21","author":"Me\u0161kyt\u0117","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105295_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1535-6108(03)00220-4","article-title":"Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model","volume":"4","author":"Meuwissen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115446","article-title":"CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7\/c-Myc-dependent axis","volume":"209","author":"Mo","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.critrevonc.2026.105295_bib89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","article-title":"MYC Drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition","volume":"31","author":"Mollaoglu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccell.2018.02.004","article-title":"PKM1 confers metabolic advantages and promotes cell-autonomous tumor cell growth","volume":"33","author":"Morita","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib91","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2008.10.018","article-title":"Distinct thresholds govern Myc's biological output in vivo","volume":"14","author":"Murphy","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib92","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","article-title":"Repression of the type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma","volume":"10","author":"Muthalagu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib93","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","article-title":"Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade","volume":"42","author":"Nabet","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41388-024-03202-1","article-title":"Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15","volume":"44","author":"Niu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105295_bib95","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.348295.121","article-title":"ASCL1 represses a SOX9(+) neural crest stem-like state in small cell lung cancer","volume":"35","author":"Olsen","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105295_bib96","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2217\/fon-2019-0317","article-title":"REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer","volume":"15","author":"Oronsky","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib97","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/2159-8290.CD-18-0389","article-title":"Cells lacking the RB1 tumor suppressor gene are hyperdependent on aurora B kinase for survival","volume":"9","author":"Oser","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jtho.2019.10.013","article-title":"Randomized phase II study of paclitaxel plus alisertib versus paclitaxel plus placebo as second-line therapy for SCLC: primary and correlative biomarker analyses","volume":"15","author":"Owonikoko","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib99","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jtho.2019.10.013","article-title":"Randomized phase II study of paclitaxel plus alisertib versus paclitaxel plus placebo as second-line therapy for SCLC: primary and correlative biomarker analyses","volume":"15","author":"Owonikoko","year":"2020","journal-title":"Journal thoracic oncology official publication International Association Study Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/2159-8290.CD-23-0656","article-title":"Acquired cross-resistance in small cell lung cancer due to extrachromosomal DNA amplification of MYC paralogs","volume":"14","author":"Pal Choudhuri","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc2578","article-title":"Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer","volume":"7","author":"Patel","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105295_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2016.02.011","article-title":"HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma","volume":"29","author":"Pei","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib103","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1541-7786.MCR-23-0599","article-title":"MYC family amplification dictates sensitivity to BET bromodomain protein inhibitor mivebresib (ABBV075) in small-cell lung cancer","volume":"22","author":"Plotnik","year":"2024","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib104","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-22-0796","article-title":"Extrachromosomal DNA amplification contributes to small cell lung cancer heterogeneity and is associated with worse outcomes","volume":"13","author":"Pongor","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib105","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.21037\/tlcr-23-505","article-title":"Does subtyping of high-grade pulmonary neuroendocrine carcinomas have an impact on therapy selection?","volume":"12","author":"Popper","year":"2023","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib106","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1200\/JCO.2021.39.15_suppl.8508","article-title":"Real-world multiomic characterization of small cell lung cancer subtypes to reveal differential expression of clinically relevant biomarkers","volume":"39","author":"Puri","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1609775","article-title":"MYCL1 amplification and expression of L-Myc and c-Myc in surgically resected small-cell lung carcinoma","volume":"27","author":"Qin","year":"2021","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib108","article-title":"Nuclear to cytoplasmic transport is a druggable dependency in HDAC7-driven small cell lung cancer","volume":"12","author":"Qin","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2026.105295_bib109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtho.2021.08.763","article-title":"Molecular subtypes of primary SCLC tumors and their associations with neuroendocrine and therapeutic markers","volume":"17","author":"Qu","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib110","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/1097-0142(19821215)50:12<2894::AID-CNCR2820501232>3.0.CO;2-G","article-title":"The clinical behavior of \"mixed\" small cell\/large cell bronchogenic carcinoma compared to \"pure\" small cell subtypes","volume":"50","author":"Radice","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib111","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","article-title":"CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation","volume":"18","author":"Rakhra","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105295_bib112","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/281452a0","article-title":"Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation","volume":"281","author":"Roussel","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105295_bib114","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.2910540123","article-title":"Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts","volume":"54","author":"Rygaard","year":"1993","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib116","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105295_bib117","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1111\/febs.14660","article-title":"The structure of INI1\/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI\/SNF chromatin remodeling complex","volume":"285","author":"Sammak","year":"2018","journal-title":"Febs J."},{"key":"10.1016\/j.critrevonc.2026.105295_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022284","article-title":"The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy","volume":"6","author":"Savino","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105295_bib119","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.critrevonc.2026.105295_bib120","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple ras-dependent phosphorylation pathways regulate Myc protein stability","volume":"14","author":"Sears","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105295_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/865819","article-title":"Regulation of SRC family kinases in human cancers","volume":"2011","author":"Sen","year":"2011","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.critrevonc.2026.105295_bib122","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41571-024-00914-x","article-title":"Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer","volume":"21","author":"Sen","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib123","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1158\/0008-5472.CAN-16-3409","article-title":"CHK1 inhibition in small-cell lung cancer produces single-agent activity in biomarker-defined disease subsets and combination activity with cisplatin or olaparib","volume":"77","author":"Sen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/jvi.31.2.514-521.1979","article-title":"DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus","volume":"31","author":"Sheiness","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jvi.28.2.600-610.1978","article-title":"Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29","volume":"28","author":"Sheiness","year":"1978","journal-title":"J. Virol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib126","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/0008-5472.CAN-19-3971","article-title":"Inhibition of the MYC-regulated glutaminase metabolic axis is an effective synthetic lethal approach for treating chemoresistant ovarian cancers","volume":"80","author":"Shen","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","article-title":"Challenges of small cell lung cancer heterogeneity and phenotypic plasticity","volume":"25","author":"Simpson","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib128","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/2159-8290.CD-22-0620","article-title":"Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation","volume":"13","author":"Sivakumar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib129","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/2159-8290.CD-22-0620","article-title":"Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation","volume":"13","author":"Sivakumar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-025-00382-6","article-title":"Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation","volume":"13","author":"Solta","year":"2025","journal-title":"Cancer Metab."},{"key":"10.1016\/j.critrevonc.2026.105295_bib131","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.1207310109","article-title":"A framework for identification of actionable cancer genome dependencies in small cell lung cancer","volume":"109","author":"Sos","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105295_bib132","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.cdd.4401443","article-title":"Omomyc expression in skin prevents Myc-induced papillomatosis","volume":"11","author":"Soucek","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.critrevonc.2026.105295_bib133","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/gad.205542.112","article-title":"Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice","volume":"27","author":"Soucek","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2026.105295_bib134","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, Metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib135","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41467-020-16447-7","article-title":"MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies","volume":"11","author":"Swaminathan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105295_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110814","article-title":"WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC","volume":"39","author":"Taniguchi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107771","article-title":"C-Myc-induced hypersialylation of small cell lung cancer facilitates pro-tumoral phenotypes of macrophages","volume":"26","author":"Tian","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2026.105295_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108296","article-title":"SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures","volume":"33","author":"Tlemsani","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib139","doi-asserted-by":"crossref","first-page":"274","DOI":"10.21037\/tlcr-20-359","article-title":"small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit","volume":"10","author":"Tomita","year":"2021","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib141","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jtho.2024.10.004","article-title":"Clinical significance of a prospective large genomic screening for SCLC: the genetic classification and a biomarker-driven phase 2 trial of gedatolisib","volume":"20","author":"Umemura","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib142","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41568-019-0128-6","article-title":"Extrachromosomal oncogene amplification in tumour pathogenesis and evolution","volume":"19","author":"Verhaak","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105295_bib143","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.embor.embor821","article-title":"Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP","volume":"4","author":"Vervoorts","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.critrevonc.2026.105295_bib144","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41392-025-02378-6","article-title":"Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105295_bib145","article-title":"Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in small cell lung cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib146","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00018-011-0860-x","article-title":"Tumor microenvironment: becoming sick of Myc","volume":"69","author":"Whitfield","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105295_bib147","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-20-3108","article-title":"Drugging the \"undruggable\" MYCN oncogenic transcription factor: overcoming previous obstacles to impact childhood cancers","volume":"81","author":"Wolpaw","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007343","article-title":"Systems-level network modeling of small cell lung cancer subtypes identifies master regulators and destabilizers","volume":"15","author":"Wooten","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib149","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41586-019-1763-5","article-title":"Circular ecDNA promotes accessible chromatin and high oncogene expression","volume":"575","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105295_bib150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2159-8290.CD-21-1376","article-title":"Live-cell imaging shows uneven segregation of extrachromosomal dna elements and transcriptionally active extrachromosomal DNA hubs in cancer","volume":"12","author":"Yi","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105295_bib151","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1158\/1078-0432.CCR-24-3399","article-title":"Amplification of extrachromosomal MYC paralogs shapes immunosuppressive tumor microenvironment in small cell lung cancer","volume":"31","author":"Zhang","year":"2025","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105295_bib152","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41419-024-06950-w","article-title":"BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105295_bib153","article-title":"c-Myc Targets HDAC3 to suppress NKG2DL expression and innate immune response in N-type SCLC through histone deacetylation","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105295_bib154","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/leu.2013.94","article-title":"Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity","volume":"27","author":"Zhao","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105295_bib155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jmcb\/mjy072","article-title":"Mutant p53 in cancer therapy-the barrier or the path","volume":"11","author":"Zhou","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105295_bib156","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00428-024-03754-3","article-title":"Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer","volume":"486","author":"Zhu","year":"2025","journal-title":"Virchows Arch."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:47:51Z","timestamp":1778482071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":156,"alternative-id":["S1040842826001824"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105295","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The oncogene c-MYC: An orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105295"}}